The global market for hydroxychloroquine sulfate tablets is expected to grow at a significant CAGR during the forecast period (2021-2027). Hydroxychloroquine is a safer chloroquine derivative. Although the medication is ineffective for chloroquine-resistant malaria, hydroxychloroquine is an immunosuppressive and anti-parasite therapy used to treat or prevent malaria. When other medicines fail or cannot be used to treat autoimmune disorders including systemic and discoid lupus erythematosus and rheumatoid arthritis (acute and severe), hydroxychloroquine is recommended. A variety of viruses can be treated using broad-spectrum hydroxychloroquine Sulfate tablets. According to the China's Ministry of Science and Technology, hydroxychloroquine is one of the medicines that has shown to be effective in preventing coronavirus infection in the early clinical trials.

Free Sample Copy @ https://www.omrglobal.com/request-sample/hydroxychloroquine-sulfate-tablets-market

Increased malaria incidence and increased need for effective and safe treatment are expected to drive up demand. Due to its effectiveness against a wide range of parasite types, hydroxychloroquine Sulfate tablets are frequently employed in the treatment of malaria. The incidence of malaria in Africa reached 210,000 cases in 2018, which is expected to increase demand for hydroxychloroquine Sulfate tablets. Furthermore, the market for hydroxychloroquine Sulfate is expected to grow due to its easy availability, low cost, and ability to decrease platelet loss.

A Full Report of Hydroxychloroquine Sulfate Tablets Market is Available at:
https://www.omrglobal.com/industry-reports/hydroxychloroquine-sulfate-tablets-market

Furthermore, rising occurrences of skin lesions and psoriasis as a result of rising pollution levels and poor diets are expected to drive up demand. Due to its antibacterial properties and capacity to inhibit aberrant skin cell development, hydroxychloroquine Sulfate is commonly recommended to treat skin disorders. It is water soluble and may be utilized in paediatric medicine, thus demand is expected to rise. The hydroxychloroquine Sulfate market is expected to grow due to increased awareness of dermatological aspects of healthcare and increased desire for quick-acting treatments.

Hydroxychloroquine Sulfate Tablets Market – Segmentation
By Product
100 mg
200 mg
By Application
Hospital Pharmacy
Retail Pharmacy
By Disease
Malaria
Arthritis
Skin Lesions
Lupus
COVID-19

Hydroxychloroquine Sulfate Tablets Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Teva Pharmaceutical Industries Ltd.
Mylan
Novartis
Hikma Pharmaceuticals
Ipca Laboratories
Shanghai Pharmaceuticals Holding Co. Ltd.
Sanofi
Taj Pharmaceuticals Limited
Cinkate Corporation
Concordia Healthcare

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hydroxychloroquine-sulfate-tablets-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404